These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 28925887)
21. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity. Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466 [TBL] [Abstract][Full Text] [Related]
22. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Khan MA; Pandit J; Sultana Y; Sultana S; Ali A; Aqil M; Chauhan M Drug Deliv; 2015; 22(6):795-802. PubMed ID: 24735246 [TBL] [Abstract][Full Text] [Related]
23. Formulation and assessment of hydroxyzine HCL solid lipid nanoparticles by dual emulsification technique for transdermal delivery. El-Telbany DFA; El-Telbany RFA; Zakaria S; Ahmed KA; El-Feky YA Biomed Pharmacother; 2021 Nov; 143():112130. PubMed ID: 34560549 [TBL] [Abstract][Full Text] [Related]
24. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach. Mannam R; Yallamalli IM Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185 [TBL] [Abstract][Full Text] [Related]
26. Optimization of Nanostructured Lipid Carriers of Lurasidone Hydrochloride Using Box-Behnken Design for Brain Targeting: In Vitro and In Vivo Studies. Jazuli I; Annu ; Nabi B; Moolakkadath T; Alam T; Baboota S; Ali J J Pharm Sci; 2019 Sep; 108(9):3082-3090. PubMed ID: 31077685 [TBL] [Abstract][Full Text] [Related]
27. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation. Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089 [TBL] [Abstract][Full Text] [Related]
29. Ethosomal Hydrogel of Raloxifene HCl: Statistical Optimization & Ex Vivo Permeability Evaluation Across Microporated Pig Ear Skin. Thakkar HP; Savsani H; Kumar P Curr Drug Deliv; 2016; 13(7):1111-1122. PubMed ID: 26787414 [TBL] [Abstract][Full Text] [Related]
30. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride. Naguib MJ; Elsayed I; Teaima MH Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861 [TBL] [Abstract][Full Text] [Related]
31. Enhancement of the bioavailability of an antihypertensive drug by transdermal protransfersomal system: formulation and in vivo study. Morsi NM; Aboelwafa AA; Dawoud MHS J Liposome Res; 2018 Jun; 28(2):137-148. PubMed ID: 28264602 [TBL] [Abstract][Full Text] [Related]
32. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485 [TBL] [Abstract][Full Text] [Related]
33. Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment. Garg V; Singh H; Bhatia A; Raza K; Singh SK; Singh B; Beg S AAPS PharmSciTech; 2017 Jan; 18(1):58-71. PubMed ID: 26868380 [TBL] [Abstract][Full Text] [Related]
34. Development of an optimized avanafil-loaded invasomal transdermal film: Ex vivo skin permeation and in vivo evaluation. Ahmed OAA; Badr-Eldin SM Int J Pharm; 2019 Oct; 570():118657. PubMed ID: 31491483 [TBL] [Abstract][Full Text] [Related]
35. Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. Ranch KM; Maulvi FA; Naik MJ; Koli AR; Parikh RK; Shah DO Int J Pharm; 2019 Jan; 554():264-275. PubMed ID: 30423418 [TBL] [Abstract][Full Text] [Related]
36. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling. Elkomy MH; Elmenshawe SF; Eid HM; Ali AM Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization. Khalil RM; Abdelbary A; Kocova El-Arini S; Basha M; El-Hashemy HA J Liposome Res; 2019 Jun; 29(2):171-182. PubMed ID: 30221568 [TBL] [Abstract][Full Text] [Related]
38. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Baek JS; Pham CV; Myung CS; Cho CW Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175 [TBL] [Abstract][Full Text] [Related]
39. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Elgindy NA; Mehanna MM; Mohyeldin SM Int J Pharm; 2016 Mar; 501(1-2):167-79. PubMed ID: 26828671 [TBL] [Abstract][Full Text] [Related]
40. Optimization of elastic transfersomes formulations for transdermal delivery of pentoxifylline. Al Shuwaili AH; Rasool BK; Abdulrasool AA Eur J Pharm Biopharm; 2016 May; 102():101-14. PubMed ID: 26925505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]